762199-99-5Relevant academic research and scientific papers
6,7-Dichloro-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline.A Structurally Novel β-Adrenergic Receptor Blocking Agent
Kaiser, Carl,Oh, Hye-Ja,Garcia-Slanga, Blanche J.,Sulpizio, Anthony C.,Hieble, J. Paul,et al.
, p. 2381 - 2384 (1986)
Replacement of the catecholic hydroxyl groups of the β-adrenergic receptor agonist 6,7-dihydroxy-1-(3,4,5-trimethoxybenzyl)-1,2,3,4-tetrahydroisoquinoline (trimetoquinol) with chloro substituents results in a compound with marked β-adrenoceptor antagonist
